A Novel Pathogenic NOD2 Variant in a Mother and Daughter with Blau Syndrome

References

• Rotenstein D, Gibbas DL, Majmudar B, Chastain EA. 1982. Familial granulomatous arteritis with polyarthritis of juvenile onset. N Engl J Med. 306(2):86–90. doi:https://doi.org/10.1056/NEJM198201143060208
   PubMed Web of Science ®Google Scholar
• Blau EB. 1985. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 107(5):689–93. doi:https://doi.org/10.1016/S0022-3476(85)80394-2
   PubMed Web of Science ®Google Scholar
• Jabs DA, Houk JL, Bias WB, Arnett FC. 1985. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 78(5):801–04. doi:https://doi.org/10.1016/0002-9343(85)90286-4
   PubMed Web of Science ®Google Scholar
• Miceli-Richard C, Lesage S, Rybojad M, Prieur A-M, Manouvrier-Hanu S, Häfner R, Chamaillard M, Zouali H, Thomas G, Hugot J-P. CARD15 mutations in Blau syndrome. Nat Genet. 2001 Sep;29(1):19–20. doi:https://doi.org/10.1038/ng720.
   PubMed Web of Science ®Google Scholar
• Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y. 2004. Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J Invest Dermatol. 122(3):851–52. doi:https://doi.org/10.1111/j.0022-202X.2004.22341.x
   PubMed Web of Science ®Google Scholar
• Rosé CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP, Martin TM. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol. 2005 Feb;32(2):373–75.
   PubMed Web of Science ®Google Scholar
• Touitou I Infevers: an online database for autoinflammatory mutations. Accessed November 24, 2020. https://infevers.umai-montpellier.fr/
   Google Scholar
• De Menthière CS. 2003. INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res. 31(1):282–85. doi:https://doi.org/10.1093/nar/gkg031
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067. doi:https://doi.org/10.1093/nar/gkx1153.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. ACMG laboratory quality assurance committee. standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–23. doi:https://doi.org/10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012 Jul;40( Web Server issue):W452–7. doi:https://doi.org/10.1093/nar/gks539.
   PubMed Web of Science ®Google Scholar
• Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using polyPhen-2. Curr Protoc Hum Genet. 2013; 2. doi:https://doi.org/10.1002/0471142905.hg0720s76
   Google Scholar
• Kircher M, Witten DM, Jain P, O’roak BJ, Cooper GM, Shendure J. 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 46(3):310–15. doi:https://doi.org/10.1038/ng.2892
   PubMed Web of Science ®Google Scholar
• Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A. 2005. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15(7):901–13. doi:https://doi.org/10.1101/gr.3577405
   PubMed Web of Science ®Google Scholar
• Genome Aggregation Database (gnomAD). Accessed June 16, 2020. https://gnomad.broadinstitute.org/
   Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43. doi:https://doi.org/10.1038/s41586-020-2308-7.
   PubMed Web of Science ®Google Scholar
• Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA. Accessed November 5, 2020. http://evs.gs.washington.edu/EVS/
   Google Scholar
• Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526(7571):68–74. https://doi.org/10.1038/nature15393.
   PubMed Web of Science ®Google Scholar
• Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33. https://doi.org/10.1186/1546-0096-12-33.
   PubMed Web of Science ®Google Scholar
• Chen G, Shaw MH, Kim Y-G NG. 2009. NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol Mech Dis. 4(1):365–98. doi:https://doi.org/10.1146/annurev.pathol.4.110807.092239
   PubMed Web of Science ®Google Scholar
• Zurek B, Proell M, Wagner RN, Schwarzenbacher R, Kufer TA. 2012. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation. Innate Immunity. 18(1):100–11. doi:https://doi.org/10.1177/1753425910394002
   PubMed Web of Science ®Google Scholar
• Rose CD, Martin TM. 2005. Caspase recruitment domain 15 mutations and rheumatic diseases. Curr Opin Rheumatol. 17(5):579–85. doi:https://doi.org/10.1097/01.bor.0000169362.61443.52
   PubMed Web of Science ®Google Scholar
• Napier RJ, Lee EJ, Davey MP, Vance EE, Furtado JM, Snow PE, Samson KA, Lashley SJ, Brown BR, Horai R, et al. T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis. Nat Commun. 2020 Oct 26;11(1):5406. doi:https://doi.org/10.1038/s41467-020-18961-0.
   PubMed Web of Science ®Google Scholar
• Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. 2010. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. 134(3):251–61. doi:https://doi.org/10.1016/j.clim.2009.05.005
   PubMed Web of Science ®Google Scholar
• Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud BP, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J. Blau Syndrome–associated uveitis: preliminary results from an international prospective interventional case series. Am J Ophthalmol. 2018Mar;187: 158–66.https://doi.org/10.1016/j.ajo.2017.08.017.
   PubMed Web of Science ®Google Scholar
• Rose CD. 2017. Blau syndrome: a systemic granulomatous disease of cutaneous onset and phenotypic complexity. Pediatr Dermatol. 34(2):216–18. doi:https://doi.org/10.1111/pde.13021
   PubMed Web of Science ®Google Scholar
• Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003;100(6):3455–60. doi:https://doi.org/10.1073/pnas.0530276100.
   PubMed Web of Science ®Google Scholar
• Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappa B activation: common genetic etiology with Blau syndrome. Blood. 2004;105(3):1195–97. doi:https://doi.org/10.1182/blood-2004-07-2972.
   PubMed Web of Science ®Google Scholar
• Sakai H, Ito S, Nishikomori R, Takaoka Y, Kawai T, Saito M, Okafuji I, Yasumi T, Heike T, Nakahata T. 2010. A case of early-onset sarcoidosis with a six-base deletion in the NOD2 gene. Rheumatology (Oxford). 49(1):194–96. doi:https://doi.org/10.1093/rheumatology/kep315
   PubMed Web of Science ®Google Scholar
• Chauhan K, Michet C. A Case of Blau Syndrome. Case Rep Rheumatol. 2014;2014:1–3. https://doi.org/10.1155/2014/216056.
   Google Scholar
• Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998 Oct;25(10):1991–94.
   PubMedGoogle Scholar
• Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, et al. International League of Associations for Rheumatology. international League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004 Feb;31(2):390–92.
   PubMed Web of Science ®Google Scholar
• Carreño E, Guly CM, Chilov M, Hinchcliffe A, Arostegui JI, Lee RWJ, Dick AD, Ramanan AV. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome). Acta Ophthalmol. 2015 May;93(3):253–57. doi:https://doi.org/10.1111/aos.12544.
   PubMed Web of Science ®Google Scholar
• Rosé CD, Wouters CH, Meiorin S, Doyle TM, Davey MP, Rosenbaum JT, Martin TM. Pediatric Granulomatous Arthritis An International Registry. Arthritis Rheum. 2006;54(10):3337–44. doi:https://doi.org/10.1002/art.22122.
   Google Scholar
• Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, et al. Blau syndrome:  cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology. 2015;( May 2014): 1008–16. doi:https://doi.org/10.1093/rheumatology/keu437
   Google Scholar
• Aróstegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, García-Consuegra J, Naranjo A, Ramos E, de Paz P, et al. NOD2 gene–associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 2007;56(11):3805–13. doi:https://doi.org/10.1002/art.22966.
   PubMed Web of Science ®Google Scholar
• Rose CD, Neven B, Wouters CH. 2014. Granulomatous inflammation: the overlap of immune deficiency and inflammation. Best Pract Res Clin Rheumatol. 28(2):191–212. doi:https://doi.org/10.1016/j.berh.2014.03.006
   PubMed Web of Science ®Google Scholar
• Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13(12):1220–29. doi:https://doi.org/10.1016/j.autrev.2014.08.010.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA. 2019. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 103(10):1418–22. doi:https://doi.org/10.1136/bjophthalmol-2018-313356
   PubMed Web of Science ®Google Scholar
• Gundlach E, Hoffmann MM, Prasse A, Heinzelmann S, Ness T, Rosenbaum JT. 2016. Interleukin-2 receptor and angiotensin-con-verting enzyme as markers for ocular sarcoidosis. PLoS One. 11(1):e0147258. doi:https://doi.org/10.1371/journal.pone.0147258
   PubMed Web of Science ®Google Scholar
• Thi Hong Nguyen C, Kambe N, Kishimoto I, Ueda-Hayakawa I, Okamoto H. 2017. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement. J Dermatol. 44(7):789–97. doi:https://doi.org/10.1111/1346-8138.13792
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis 1999;16:149–73.
   PubMed Web of Science ®Google Scholar
• Newman LS, Rose CS, Maier LA. 1997. Sarcoidosis. N Engl J Med. 336(17):1224–34. doi:https://doi.org/10.1056/NEJM199704243361706
   PubMed Web of Science ®Google Scholar
• Yamamoto M, OP Sharma YH. Special report: the 1991 descriptive definition of sarcoidosis. Sarcoidosis. 1992;9:33–34.
   Google Scholar
• Testi I, Agrawal R, Mehta S, Basu S, Nguyen Q, Pavesio C, Gupta V. Ocular tuberculosis: where are we today? Indian J Ophthalmol. 2020 Sep;68(9):1808–17. doi:https://doi.org/10.4103/ijo.IJO_1451_20.
   PubMed Web of Science ®Google Scholar
• Petrushkin H, Sethi C, Potter J, Martin L, Russell G, White V, Ajamil-Rodanes S, Brown M, Breen R, Lipman M, et al. Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon Ocular tuberculosis Pathway—LOOP. Eye Published online. 2019;7–10. doi:https://doi.org/10.1038/s41433-019-0543-7.
   Google Scholar
• Troncoso LL, Biancardi AL, de Moraes Jr HV, Zaltman C. 2017. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 23(32):5836–48. doi:https://doi.org/10.3748/wjg.v23.i32.5836
   PubMed Web of Science ®Google Scholar
• Ottaviano G, Salvatore S, Salvatoni A, Martelossi S, Ventura A, Naviglio S. 2018. Ocular manifestations of paediatric inflammatory bowel disease: a systematic review and meta-analysis. J Crohn’s Colitis. 12(7):870–79. doi:https://doi.org/10.1093/ecco-jcc/jjy029
   Google Scholar
• Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11(1):3–25. doi:https://doi.org/10.1093/ecco-jcc/jjw168.
   Google Scholar
• Menees SB, Powell C, Kurlander J, Goel A, Chey WD. 2015. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol. 110(3):444–54. doi:https://doi.org/10.1038/ajg.2015.6
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I. 2017. Systemic vasculitis and the eye. Curr Opin Rheumatol. 29(1):24–32. doi:https://doi.org/10.1097/BOR.0000000000000345
   PubMed Web of Science ®Google Scholar
• Jesus AA, Fujihira E, Watase M, Terreri MT, Hilario MO, Carneiro-Sampaio M, Len CA, Oliveira SK, Rodrigues MC, Pereira RM, et al. Hereditary autoinflammatory syndromes: a Brazilian multicenter study. J Clin Immunol. 2012;32(5):922–32. doi:https://doi.org/10.1007/s10875-012-9688-x.
   PubMed Web of Science ®Google Scholar
• Poline J, Fogel O, Pajot C, Miceli‐Richard C, Rybojad M, Galeotti C, Grouteau E, Hachulla E, Brissaud P, Cantagrel A, et al. Early-onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome. J Eur Acad Dermatol Venereol. 2020;34(2):340–48. doi:https://doi.org/10.1111/jdv.15963.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhong L, Sun Z, Zhu T, Song H, Sui R. Ocular Features in Chinese Patients with Blau Syndrome. Ocul Immunol Inflamm. February 26 2019:1–7. doi:https://doi.org/10.1080/09273948.2019.1569239. Published online.
   Google Scholar
• Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, Kawakami A, Takei S, Tonomura K, Inoue M, et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis. 2020;79(11):1492–99. doi:https://doi.org/10.1136/annrheumdis-2020-217320.
   PubMed Web of Science ®Google Scholar
• Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009;60(1):242–50. doi:https://doi.org/10.1002/art.24134.
   PubMed Web of Science ®Google Scholar
• Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, Silverman ED, Saurenmann RK, Levin AV, Feldman BM, et al. 2007. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum. 56(2):647–57. doi:https://doi.org/10.1002/art.22381
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Minden K, Föll D, Pleyer U. Uveitis in Juvenile Idiopathic Arthritis. Dtsch Arztebl Int. 2015;112(6):92–100. doi:https://doi.org/10.3238/arztebl.2015.0092. Feb 6.
   PubMed Web of Science ®Google Scholar
• Wang X, Kuivaniemi H, Bonavita G, Mutkus L, Mau U, Blau E, Inohara N, Nunez G, Tromp G, Williams CJ. 2002. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 46(11):3041–45. doi:https://doi.org/10.1002/art.10618
   PubMed Web of Science ®Google Scholar
• Koop A, Ossewaarde A, Rothova A. 2013. Peripheral multifocal chorioretinitis: complications, prognosis and relation with sarcoidosis. Acta Ophthalmol. 91(6):492–97. doi:https://doi.org/10.1111/j.1755-3768.2012.02483.x
   PubMed Web of Science ®Google Scholar
• Saleh MGA, O’Donnell JL, Davis RP, Wilson D, Lin P. 2019. Clinical pathologic correlation of sarcoidosis-associated chorioretinitis in an elderly patient. Retin Cases Br Reports. 13(2):154–57. doi:https://doi.org/10.1097/ICB.0000000000000547
   PubMedGoogle Scholar
• Ongchin S, Keene CD, van Gelder R, Vemulakonda GA. 2013. A diagnostic dilemma: infectious versus noninfectious multifocal choroiditis with panuveitis. J Ophthalmic Inflamm Infect. 3(1):1–4. doi:https://doi.org/10.1186/1869-5760-3-26
   PubMedGoogle Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411(6837):603–06. doi:https://doi.org/10.1038/35079114.
   PubMed Web of Science ®Google Scholar
• Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cézard J-P, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411(6837):599–603. doi:https://doi.org/10.1038/35079107.
   PubMed Web of Science ®Google Scholar
• Rahman N, Petrushkin H, Solebo AL. Paediatric autoimmune and autoinflammatory conditions associated with uveitis. Therapeutic Advances in Ophthalmology. 2020;12:251584142096645. https://doi.org/10.1177/2515841420966451.
   Web of Science ®Google Scholar
• Chen J, Luo Y, Zhao M, Wu D, Yang Y, Zhang W, Shen M. 2019. Effective treatment of TNFα inhibitors in Chinese patients with Blau syndrome. Arthritis Res Ther. 21(1):1–7. doi:https://doi.org/10.1186/s13075-019-2017-5
   PubMed Web of Science ®Google Scholar
• Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, Cimaz R. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum. 2013;65(2):365–98. doi:https://doi.org/10.1002/art.37776.
   Web of Science ®Google Scholar
• Foley KP, Desai B, Vossenkämper A, Reilly MA, Biancheri P, Wang L, Lipshutz DB, Connor J, Miller M, Haile PA, et al. OR3-001 – RIP2 kinase is activated in Blau Syndrome and IBD. Pediatr Rheumatol. 2013;11(S1):A3. doi:https://doi.org/10.1186/1546-0096-11-s1-a3.
   PubMed Web of Science ®Google Scholar